Stay updated on Atezolizumab Subq in NSCLC: Clinical Trial
Sign up to get notified when there's something new on the Atezolizumab Subq in NSCLC: Clinical Trial page.

Latest updates to the Atezolizumab Subq in NSCLC: Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the study record content, indicating restricted access to the page. Visible additions include the 403 text and a Home link, while the previous detailed study content and navigation elements have been removed.SummaryDifference19%

- Check35 days agoChange DetectedThe page now includes a mention of the 2018 NIH Grant/Contract and updates the revision to v3.6.6, replacing the previous v3.6.5.SummaryDifference0.1%

- Check57 days agoChange DetectedThe page now displays a generic 'An error occurred' message and HTML, replacing the previous study record content. This indicates a temporary outage or server error rather than an update to the study data.SummaryDifference18%

- Check71 days agoChange DetectedThe page revision changed from v3.6.3 to v3.6.4, indicating a minor update to the page's version metadata. This update does not alter any study details, eligibility criteria, or results on the page.SummaryDifference0.0%

- Check92 days agoChange DetectedAdded a new publication citation for subcutaneous vs intravenous atezolizumab in NSCLC and removed the prior online-ahead-of-print citation, updating the referenced literature in the Publications section.SummaryDifference0.1%

- Check100 days agoChange DetectedRevision label on the page has been updated from v3.6.0 to v3.6.2, indicating a minor update to the page template or content rather than to the study information.SummaryDifference0.0%

Stay in the know with updates to Atezolizumab Subq in NSCLC: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Atezolizumab Subq in NSCLC: Clinical Trial page.